Post-marketing surveillance of ONSTI: Physician-reported clinical efficacy of a homeopathic formulation in the management of constipation
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Background: Constipation is a common functional gastrointestinal disorder characterized by infrequent bowel movements, hard stools, straining, and a sensation of incomplete evacuation. Its prevalence spans all age groups and is influenced by dietary habits, lifestyle factors, psychosomatic components, and comorbid systemic conditions. Conventional management strategies often rely on laxatives and stool softeners, which may provide symptomatic relief but are frequently associated with dependency, tolerance, or adverse effects with long-term use. Homeopathy offers an individualized, holistic approach to constipation, focusing not only on bowel habits but also on associated constitutional, metabolic, and psychosomatic factors. Multi-ingredient homeopathic formulations are widely prescribed in clinical practice for functional bowel disorders, particularly where long-term safety and gentle regulation of bowel function are priorities. ONSTI is a marketed homeopathic formulation indicated for the management of constipation. Since its introduction into routine clinical practice, it has been prescribed by physicians across diverse patient populations. In line with pharmacovigilance and regulatory expectations for marketed medicinal products, Post-Marketing Surveillance (PMS) serves as a valuable tool to assess real-world efficacy, safety, and clinical utility beyond controlled trial settings. This study was undertaken to systematically document and analyse physician experiences with ONSTI in everyday clinical practice, focusing on its efficacy in relieving constipation and improving bowel regularity. Objective: To evaluate the real-world clinical efficacy and physician-reported outcomes of ONSTI, a homeopathic medicine formulation indicated for constipation, through post-marketing surveillance data collected from practicing physicians using structured questionnaires. Methods: This observational PMS study analysed structured questionnaires completed by practicing physicians who prescribed ONSTI in routine clinical settings. The primary outcome was physician-rated overall effectiveness measured on a five-point Likert scale. Secondary outcomes included physician-reported relief and no-relief percentages in acute and chronic constipation, time to onset of symptom relief, patient age group distribution, and geographic zone. Data cleaning included duplicate checks, mode imputation for missing effectiveness scores, and wide-to-long data transformation. Normality was assessed using the Shapiro-Wilk test, and non-parametric statistical methods were applied. Results: Median relief percentages were consistently higher than no-relief percentages for both acute and chronic constipation, with no statistically significant difference between the two conditions (p>0.05). Most physicians reported symptom relief within 3-5 days of treatment initiation. A statistically significant association was observed between earlier time to relief and higher physician-rated effectiveness (p = 0.003). Overall effectiveness ratings were predominantly moderate to high and were consistent across patient age groups and geographic zones. Conclusion: Physician-reported real-world evidence suggests that ONSTI demonstrates consistent effectiveness in the management of constipation in routine clinical practice. Earlier onset of symptom relief was associated with more favourable effectiveness perceptions, supporting the clinical utility of ONSTI in everyday practice.
Fields of Study & Subjects
Complementary and Alternative Medicine Studies
Gastrointestinal motility and disorders
Pharmacovigilance and Adverse Drug Reactions
Publication details
- Journal / source
- International Journal of Homoeopathic Sciences
- Volume
- 10
- Issue
- 3
- Pages
- 758–769
- Publication date
- 1 March 2026
- Language
- EN